PUBLIC | NASDAQ:DNLI Focus on neurodegenerative diseases such as Parkinson’s and Alzheimer’s http://www.denalitherapeutics.com/ Press Releases Denali Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designation for DNL310, and Expands its Portfolio of...
PUBLIC | NASDAQ:EDIT Building the leading genome editing company dedicated to treating patients with genetically defined diseases. https://editasmedicine.com Press Releases Editas Medicine Presents Pre-Clinical Data for Treatment of Sickle Cell Disease and...
